A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance)
Titel:
A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance)
Auteur:
Vij, Ravi Le-Rademacher, Jennifer Laumann, Kristina Hars, Vera Owzar, Kouros Shore, Tsiporah Vasu, Sumithira Cashen, Amanda Isola, Luis Shea, Thomas DeMagalhaes-Silverman, Margarida Hurd, David Meehan, Kenneth Beardell, Frank Devine, Steven
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 25 (2019) nr. 10 pagina's 1984-1992
Jaar:
2019
Inhoud:
Uitgever:
American Society for Transplantation and Cellular Therapy